Tue Oct 21 08:30:14 SGT 2014  
    Vaccine, Singapore (SG)

Vaccine, Singapore (SG)


Vaccine, Singapore (SG) @singaporevaccine_com: vaccine jab/shot/injection schedule, to vaccinate against the infection, to immunise against infectious disease, Singapore. Private and confidential service. Definitions, references, and latest news.


Vaccine types available for vaccination / immunisation (uk) / immunization (us) :

Vaccine Against Disease Age D
Dose schedule Price
Live attenuated
MMR vaccine ≥12m 1 $70/=
Measles virus Measles
Mumps virus Mumps
Rubella virus Rubella
Varilrix™ Varicella zoster virus
Varicella Chickenpox 12m-12y 1 $121/=
≥13y 2 6-10w interval
Zostavax™ Herpes zoster Shingles ≥50y 1 $400/=
Stamaril® Yellow fever virus Yellow fever 9m-59y 1 10 yearly $250/=
Inactivated / Whole / Viral & Bacterial
Rabipur® Rabies virus Rabies any 3 d 0, 7, & 21 or 28 $call/=
Ixiaro® Japanese encephalitis virus Japanese encephalitis ≥17y 2 2nd: 28d after 1st $386/=
1 Booster: 12-24m after 2nd
Dukoral® Vibrio cholerae Cholera 2-6y 3 1-6w interval $113/=
1 Booster: 6m after 3rd
≥6y 2 1-6w interval
1 Booster: 2y after 2nd
Inactivated / Fractional / Protein
Intanza™ Influenza virus Influenza 18-59y 1 1 yearly $30/=
Fluarix™ Influenza virus Influenza 6-36m ½ 1 yearly $30/=
>3y 1
Tetavax Clostridium tetani Tetanus adults 3 1-2m interval
3rd @ 6-12m
after 2nd
booster 1 10 yearly
Boostrix® ≥4y 1 <10 yearly $70/=
Corynebacterium diphtheriae Diphtheria
Clostridium tetani Tetanus
Bordetella pertussis Pertussis
Whooping cough
Inactivated / Fractional / Polysaccharide / Pure
Typhim Vi® Salmonella typhi Typhoid fever >5y 1 3 yearly $48/=
Mencevax® ACWY Neisseria meningitidis
types A, C, W-135
and Y
Meningococcal meningitis >2y 1 $80/=
Inactivated / Fractional / Polysaccharide / Conjugate
Menactra® Neisseria meningitidis
types A, C, W-135
and Y
Meningococcal meningitis 2-55y 1 $220/=
Prevenar 13® (SG) /
Prevnar 13® (US)
Streptococcus pneumoniae
types 1, 3, 4, 5,
6A, 6B, 7F, 9V, 14,
18C, 19A, 19F, 23F
Pneumococcal infection 6w-6m 4 1m interval
4th @ 12-15m
7-11m 2 1m interval
12-23m 2 2m interval
2-5y 1
≥50y 1

If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.

Testing for immunity against the following is available:

Virus Antibody Test Price
Varicella zoster virus Varicella Zoster IgG Antibody $44/=
Measles virus Measles IgG Antibody $90/=
Rubella virus Rubella IgG Antibody $24/=
Hepatitis A virus Hepatitis A IgG Antibody $30/=
Hepatitis B virus Hepatitis B surface Antibody $10/=

Other vaccines not stocked


Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Vaccine, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.


Latest News

vaccine.html target=_blank rel="nofollow">OHSU, UW share $10M NIH contract to maximize vaccine effectiveness
Mon, 20 Oct 2014 20:13:00 +0100 | bizjournals.com Health Care:Biotechnology headlines
Oregon Health & Science University's Vaccine & Gene Therapy Institute was awarded a $10 million National Institutes of Health contract to develop a means to boost the effectiveness of vaccines.

Introducing Healthtech ... unlocking Portland's universe of health startups
Mon, 20 Oct 2014 20:05:00 +0100 | bizjournals.com Health Care:Biotechnology headlines
Today we are introducing a new, occasional feature called "Healthtech."

vaccine-push-ramps-up-1413762856 target=_blank rel="nofollow">Ebola Vaccine Push Ramps Up
Mon, 20 Oct 2014 14:54:36 +0100 | WSJ.com: Health
The world had little interest in Ebola in 1997, when cell biologist Nancy J. Sullivan took up her work. Today, Dr. Sullivan would likely be at the center of any potential answer to the world’s severest Ebola outbreak. (Source: WSJ.com: Health)

NewLink in $1 billion deal with Roche to develop cancer drug
Mon, 20 Oct 2014 12:08:48 +0100 | Reuters: Health
(Reuters) - NewLink Genetics Corp said it entered into an agreement with Roche Holding AG to develop NewLink's cancer immunotherapy, making the Ebola vaccine developer eligible to receive over $1 billion in milestone payments. (Source: Reuters: Health)

vaccine-news/us-fda-accepts-review-biologics-license-application-merck-and-sanofi-paste target=_blank rel="nofollow">US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine
Mon, 20 Oct 2014 12:00:00 +0100 | Merck.com - Research and Development News
Dateline City:

Ex vivo assessment of cellular immune function – applications in patient care and clinical studies
Mon, 20 Oct 2014 00:00:00 +0100 | Tissue Antigens

A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection
Mon, 20 Oct 2014 00:00:00 +0100 | BMC Research Notes
Conclusion: Neutralizing antibodies can only control the viral levels in the early days of the HIV infection whereas cell-mediated immune response is beneficial during all the stages of the infection. This study predicts that vaccine design efforts should also focus on stimulating killer T cells that target infected cells. (Source: BMC Research Notes)

Sanofi Pasteur and Immune Design to develop vaccine for herpes simplex virus
Sun, 19 Oct 2014 23:00:00 +0100 | Pharmaceutical Technology
Vaccines division Sanofi Pasteur has partnered with clinical-stage immunotherapy company Immune Design to develop herpes simplex virus (HSV) immune therapy. (Source: Pharmaceutical Technology)

Tanzania: Public Urged to Utilise Nationwide Vaccination Campaign
Sun, 19 Oct 2014 18:07:06 +0100 | AllAfrica News: Health and Medicine
[Daily News]Minister for Health and Social Welfare Dr Seif Rashid gives a dose to Najma Omary (2) during launch of the special national campaign to vaccinate children against rubella at Nyerere Square grounds in Dodoma on Saturday. (Photo by Staff Photographer (Source: AllAfrica News: Health and Medicine)

More than a decade later, SARS offers lessons on Ebola
Sun, 19 Oct 2014 13:00:00 +0100 | Los Angeles Times - Science
It was a novel virus whose early symptoms could easily be mistaken for a dozen other common afflictions. With no treatment or vaccine in hand, it bubbled up — and quickly mushroomed — in a group of poor, populous countries. (Source: Los Angeles Times - Science)